// App-Quantinova.ai

3007 : What Perfusion Parameters Best Define Ischemic Penumbra in Patients with TIA and Minor Stroke; Data from the VISION study

Researchers

Presenter

  • Jonathan I Coulter

Principal Investigators

  • Teri S Stewart

  • Mayank Goyal

  • Andrew M Demchuk

  • Ken S Butcher

  • Jenny P Tsai

  • Michael D Hill

  • Shelagh B Coutts

Medical Centers

  • Dept of Med and Dept of Community Heath Sciences,Dept of Radiology, Calgary Stroke Program, Dept of Clinical Neurosciences, Calgary, AB, Canada

  • Univ. of Alberta, Edmonton, Alberta, Canada.

  • Univ of Calgary, Dept of radiology, Calgary, AB, Canada

  • Calgary Stroke Program and Dept of Radiology, Dept of Clinical Neurosciences, Calgary, AB, Canada

  • Calgary Stroke Program and Dept of Radiology, Dept of Clinical Neurosciences, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Stroke

Biomarkers

  • Anti-Müllerian hormone

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim